Skip to Content

4214 2.5 (Onglyza saxagliptin 2.5 mg)

Generic Name: saxagliptin

Pill imprint 4214 2.5 has been identified as Onglyza saxagliptin 2.5 mg.

Onglyza is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Onglyza saxagliptin 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Onglyza saxagliptin 2.5 mg 4214 2.5
Onglyza saxagliptin 2.5 mg 4214 2.5 Front
Onglyza saxagliptin 2.5 mg 4214 2.5 Back
Onglyza saxagliptin 2.5 mg 4214 2.5
Onglyza saxagliptin 2.5 mg 4214 2.5
Onglyza
Generic Name:
saxagliptin
Imprint:
4214 2.5
Strength:
saxagliptin 2.5 mg
Color:
Yellow
Size:
8.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Dipeptidyl peptidase 4 inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Bristol-Myers Squibb
National Drug Code (NDC):
00003-4214
Inactive Ingredients:
lactose monohydrate
microcrystalline cellulose
croscarmellose sodium
magnesium stearate

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide